Moore Paul Andrew's Form 4 filing
Zymeworks Inc. (ZYME) · filed Jan 6, 2025
- Accession no.
- 0000950170-25-002501
- Filed
- Jan 6, 2025
- Trade date
- Jan 6, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $316.3K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Moore Paul AndrewCIK 0001938192 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | Common Stock | MOption exerciseAcquired | +17,166 | $0.00 | $0 | 24,533 | Direct | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −9,792 | $14.92 | −$146,096.64 | 14,741 | Direct | |
| Jan 6, 2025 | Common Stock | MOption exerciseAcquired | +20,000 | $0.00 | $0 | 34,741 | Direct | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −11,408 | $14.92 | −$170,207.36 | 23,333 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | Common Stock | MOption exerciseDisposed | −17,166 | $0.00 | $0 | 17,168 | Direct | |
| Jan 6, 2025 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 40,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.